August 2025
1. KAUSAR MA, Alshammari KF, Alenazi F, Anwar S, et al
   RAD51 and PALB2 in precision oncology: Clinical implications for HRD associated breast and ovarian cancers (Review).
   Int J Oncol. 2025;67:65.
   

   >> Share

   
   
2. LIU R, Martin TA, Jordan NJ, Ruge F, et al
   [Corrigendum] Metastasis suppressor 1 expression in human ovarian cancer: The impact on cellular migration and metastasis.
   Int J Oncol. 2025;67:64.
   

   >> Share

   
   December 2024
3. LIU Y, Xiao H, Zeng H, Xiang Y, et al
   Beyond tumor?associated macrophages involved in spheroid formation and dissemination: Novel insights for ovarian cancer therapy (Review).
   Int J Oncol. 2024;65:117.
   

   >> Share

   
   November 2024
4. ZHU Y, Yang W, Wang X, Chen M, et al
   AUP1 transcriptionally activated by KDM5B reprograms lipid metabolism to promote the malignant progression of cervical cancer.
   Int J Oncol. 2024;65:107.
   

   >> Share

   
   
5. TAN H, He Q, Gong G, Wang Y, et al
   [Corrigendum] miR-382 inhibits migration and invasion by targeting ROR1 through regulating EMT in ovarian cancer.
   Int J Oncol. 2024;65:110.
   

   >> Share

   
   October 2024
6. SUN J, Chu H, Ji J, Huo G, et al
   [Retracted] Long non?coding RNA HOTAIR modulates HLA?G expression by absorbing miR?148a in human cervical cancer.
   Int J Oncol. 2024;65:97.
   

   >> Share

   
   August 2024
7. XU S, Zhu C, Xu Q, An Z, et al
   ARID1A restrains EMT and stemness of ovarian cancer cells through the Hippo pathway.
   Int J Oncol. 2024;65:76.
   

   >> Share

   
   June 2024
8. FU M, Deng F, Chen J, Fu L, et al
   Current data and future perspectives on DNA methylation in ovarian cancer (Review).
   Int J Oncol. 2024;64:62.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share